- Marzia Bruna Gariboldi, PhD
- Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
Website | E-mail
Special Issue Introduction
Despite decade-long studies and advancements in anticancer therapeutic regimens, cancer is still one of the most lethal diseases that affect hundreds of millions of patients in the world on a daily basis. The common cancer treatment paradigm includes chemotherapy, surgery, radiation therapy, and biological therapy. However, cancer formation is a highly regulated and complex process, largely dependent on its microenvironment. This complexity highlights the need for developing novel therapies, such as target-based treatment depending on cancer phenotype and genotype, small molecules-based chemotherapy, and immunotherapy.
Aimed topics can be, but are not confined to:
- Strategies inducing tumor cell death or ICD;
- Tumor progression inhibitors;
- Novel anticancer drugs;
- Inhibition of the epithelial-mesenchymal transition.
Submission Deadline30 Nov 2022